Filing Details
- Accession Number:
- 0001618835-20-000194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-15 16:16:17
- Reporting Period:
- 2020-06-12
- Accepted Time:
- 2020-06-15 16:16:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1618835 | Evofem Biosciences Inc. | EVFM | Pharmaceutical Preparations (2834) | 208527075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726277 | J. Justin File | C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-12 | 8,500 | $3.14 | 250,408 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.
Billionaire Hedge Funds
